Metabolically Engineered Cells For The Production of Pinosylvin
    1.
    发明申请
    Metabolically Engineered Cells For The Production of Pinosylvin 审中-公开
    用于生产Pinosylvin的代谢工程细胞

    公开(公告)号:US20140024862A1

    公开(公告)日:2014-01-23

    申请号:US13732887

    申请日:2013-01-02

    IPC分类号: C12P7/22

    摘要: A genetically engineered micro-organism having an operative metabolic pathway producing cinnamoyl-CoA and producing pinosylvin therefrom by the action of a stilbene synthase is used for pinosylvin production. Said cinnamic acid may be formed from L-phenylalanine by a L-phenylalanine ammonia lyase (PAL) which is one accepting phenylalanine as a substrate and producing cinammic acid therefrom, preferably such that if the PAL also accepts tyrosine as a substrate and forms coumaric acid therefrom, the ratio Km(phenylalanine)/Km(tyrosine) for said PAL is less than 1:1 and if said micro-organism produces a cinammate-4-hydroxylase enzyme (C4H), the ratio Kcat(PAL)/Kcat(C4H) is at least 2:1.

    摘要翻译: 具有产生肉桂酰辅酶A的功能性代谢途径并通过二苯乙烯合酶的作用从其生产pinosylvin的遗传工程微生物被用于pinosylvin生产。 所说的肉桂酸可以由L-苯丙氨酸氨裂解酶(PAL)形成,L-苯丙氨酸氨裂解酶(PAL)是一种接受苯丙氨酸作为底物并由其生产肉桂酸,优选使得如果PAL也接受酪氨酸作为底物并形成香豆酸 所述PAL的比例Km(苯丙氨酸)/ Km(酪氨酸)小于1:1,如果所述微生物产生肉桂酸-4-羟化酶(C4H),则比例Kcat(PAL)/ Kcat(C4H )至少为2:1。

    METABOLICALLY ENGINEERED CELLS FOR THE PRODUCTION OF PINOSYLVIN
    2.
    发明申请
    METABOLICALLY ENGINEERED CELLS FOR THE PRODUCTION OF PINOSYLVIN 有权
    用于生产PINOSYLVIN的代表性工程细胞

    公开(公告)号:US20090317881A1

    公开(公告)日:2009-12-24

    申请号:US12374659

    申请日:2007-07-19

    IPC分类号: C12P7/22 C12N1/19

    摘要: A genetically engineered micro-organism having an operative metabolic pathway producing cinnamoyl-CoA and producing pinosylvin therefrom by the action of a stilbene synthase is used for pinosylvin production. Said cinnamic acid may be formed from L-phenylalanine by a L-phenylalanine ammonia lyase (PAL) which is one accepting phenylalanine as a substrate and producing cinammic acid therefrom, preferably such that if the PAL also accepts tyrosine as a substrate and forms coumaric acid therefrom, the ratio Km(phenylalanine)/Km(tyrosine) for said PAL is less than 1:1 and if said micro-organism produces a cinammate-4-hydroxylase enzyme (C4H), the ratio Kcat(PAL)/Kcat(C4H) is at least 2:1.

    摘要翻译: 具有产生肉桂酰辅酶A的功能性代谢途径并通过二苯乙烯合酶的作用从其生产pinosylvin的遗传工程微生物被用于pinosylvin生产。 所说的肉桂酸可以由L-苯丙氨酸氨裂解酶(PAL)形成,L-苯丙氨酸氨裂解酶(PAL)是一种接受苯丙氨酸作为底物并由其生产肉桂酸,优选使得如果PAL也接受酪氨酸作为底物并形成香豆酸 所述PAL的比例Km(苯丙氨酸)/ Km(酪氨酸)小于1:1,如果所述微生物产生肉桂酸-4-羟化酶(C4H),则比例Kcat(PAL)/ Kcat(C4H )至少为2:1。

    Metabolically engineered cells for the production of pinosylvin
    3.
    发明授权
    Metabolically engineered cells for the production of pinosylvin 有权
    用于生产pinosylvin的代谢工程细胞

    公开(公告)号:US08343739B2

    公开(公告)日:2013-01-01

    申请号:US12374659

    申请日:2007-07-19

    IPC分类号: C12P7/22

    摘要: A genetically engineered micro-organism having an operative metabolic pathway producing cinnamoyl-CoA and producing pinosylvin therefrom by the action of a stilbene synthase is used for pinosylvin production. Said cinnamic acid may be formed from L-phenylalanine by a L-phenylalanine ammonia lyase (PAL) which is one accepting phenylalanine as a substrate and producing cinammic acid therefrom, preferably such that if the PAL also accepts tyrosine as a substrate and forms coumaric acid therefrom, the ratio Km(phenylalanine)/Km(tyrosine) for said PAL is less than 1:1 and if said micro-organism produces a cinammate-4-hydroxylase enzyme (C4H), the ratio Kcat(PAL)/Kcat(C4H) is at least 2:1.

    摘要翻译: 具有产生肉桂酰辅酶A的功能性代谢途径并通过二苯乙烯合酶的作用从其生产pinosylvin的遗传工程微生物被用于pinosylvin生产。 所说的肉桂酸可以由L-苯丙氨酸氨裂解酶(PAL)形成,L-苯丙氨酸氨裂解酶(PAL)是一种接受苯丙氨酸作为底物并由其生产肉桂酸,优选使得如果PAL也接受酪氨酸作为底物并形成香豆酸 所述PAL的比例Km(苯丙氨酸)/ Km(酪氨酸)小于1:1,如果所述微生物产生肉桂酸-4-羟化酶(C4H),则比例Kcat(PAL)/ Kcat(C4H )至少为2:1。

    RECOVERY OF STILBENOIDS
    4.
    发明申请
    RECOVERY OF STILBENOIDS 审中-公开
    恢复STILBENOIDS

    公开(公告)号:US20110086399A1

    公开(公告)日:2011-04-14

    申请号:US12937508

    申请日:2009-04-08

    IPC分类号: C12P7/22

    CPC分类号: C12P7/22

    摘要: A cis- or trans-stilbenoid of the general formula (1) in which each of R1, R2, R3, R4 and R5 is hydrogen or hydroxy, or a glycosylated or oligomeric form thereof, such as resveratrol or pinosylvin is produced by cultivating a microorganism such as a genetically engineered yeast to produce said stilbenoid in a culture medium in solid form, and is separated by filtration or settling.

    摘要翻译: 其中R1,R2,R3,R4和R5各自为氢或羟基的通式(1)的顺式或反式芪类化合物,或其糖基化或寡聚体形式,如白藜芦醇或豆蔻糖醇,是通过培养 微生物如遗传工程酵母,以固体形式在培养基中产生所述茋,并通过过滤或沉降分离。